Medtronic HeartWare Recall Given Most Serious Designation By FDA
The FDA says problems with Medtronic Heartware HVAD implants, which resulted in its removal from the market, put patients at risk of severe injury or death.
The FDA says problems with Medtronic Heartware HVAD implants, which resulted in its removal from the market, put patients at risk of severe injury or death.
A new report indicates the FDA and Medtronic knew of HeartWare implant problems and deaths for years, but took little action to make the devices safer and kept allowing them…
After issuing a series of Class I recalls for HeartWare HVAD systems over the past decade, Medtronic has announced that it will remove the cardiac devices from the market, as…
Another Medtronic HeartWare HVAD recall has been issued, this time to clarify instructions which, if misinterpreted, could lead to serious injuries and deaths.
The latest in a series of Medtronic HeartWare HVAD recalls in recent years comes after at least 12 deaths and hundreds of complaints of problems with battery cables and data…
A Medtronic HeartWare HVAD implant recall warns that a defective screw could result in delay in treatment, bleeding injuries, and death.
Federal regulators have announced a class I recall for the Medtronic HeartWare HVAD cardiac device, indicating that it may stop working, posing a risk of serious injury or death for…
Two recent HeartWare Ventricular Assist Device recalls have been given Class I designations by the FDA, meaning they carry a serious risk of severe injury or death.
Another HVAD recall has been announced, this time involving heart pump controllers that may have loose connections.
A risk of malfunctions that could cause serious injury or death has led to the recall of some Heartware Ventricular Assist Device heart pumps.